Management — Reza Parsa Nejad, PhD
President, CytoPrecission
Dr. Reza Parsa Nejad is the Founder and President of CytoPrecission, bringing over 15 years of academic and industry experience in molecular biology, medical diagnostics, and pharmaceutical research.
With a strong foundation in biomedical sciences and an extensive background in translational research, Dr. Parsa Nejad has worked across multiple roles — including Research Scientist, Consultant, Postdoctoral Fellow, and Research Associate — supporting projects in drug development, biomarker discovery, and infectious disease diagnostics.
Prior to founding CytoPrecission, Dr. Parsa Nejad served as a Research Fellow at McGill University, where he contributed to cutting-edge studies in molecular biology and clinical microbiology. His expertise bridges both laboratory science and applied medical research, enabling him to guide clients through scientifically rigorous and regulatory-aligned research strategies.
Education
- PhD in Molecular Biology
- MSc in Medical Microbiology
- BSc in Biology
Expertise
- Clinical and molecular diagnostics
- Infectious disease research and immunology
- Biomarker identification and validation
- Study design and scientific consulting for pharmaceutical and biotech sectors
- Regulatory and translational strategy for early-stage R&D
At CytoPrecission
As President of CytoPrecission, Dr. Parsa Nejad leads with a focus on precision, scientific integrity, and client partnership. His vision is to provide small to mid-sized pharmaceutical and biotech organizations with high-impact consulting services that accelerate innovation while ensuring scientific and regulatory excellence.
